Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

VTR

Ventas (VTR) Reports Strong Q1 Earnings

Ventas reported first-quarter 2026 attributable net income per share of $0.11, up from $0.10 a year earlier. Normalized FFO per share rose 9% to $0.94 from $0.86, while NAREIT FFO per share increased 6% to $0.90 from $0.85.

Operating performance accelerated in the senior housing operating portfolio. Same-store cash NOI grew more than 15% year over year, supported by nearly 9% same-store cash operating revenue growth, 310 basis points of average occupancy improvement, and 5% growth in revenue per occupied room. Ventas said NOI margin expanded by 170 basis points. U.S. SHOP same-store average occupancy increased 370 basis points.

Across the company, total NOI rose 14% year over year and total company same-store cash NOI increased 9%.

Investment activity picked up sharply. Ventas closed $1.0 billion of senior housing investments in the first quarter and $1.7 billion year to date through April 2026. It raised its 2026 investment target to $3 billion from $2.5 billion.

Funding activity also moved quickly. During the first quarter, the company settled 10.6 million shares under equity forward sales agreements, generating $0.8 billion in net proceeds. Combined with $1.6 billion of unsettled forward sales agreements outstanding, that brought total equity capital tied to those agreements to $2.4 billion.

Balance sheet leverage improved again. Net debt-to-further adjusted EBITDA fell to 5.0x at quarter-end, marking the tenth straight quarter of sequential improvement. Liquidity stood at $5.5 billion at March 31, 2026. Today the company's shares have moved 0.83% to a price of $83.62. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS